tradingkey.logo

Exact Sciences Corp

EXAS
View Detailed Chart

45.640USD

+0.850+1.90%
Close 04/30, 16:00ETQuotes delayed by 15 min
8.47BMarket Cap
LossP/E TTM

Exact Sciences Corp

45.640

+0.850+1.90%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.90%

5 Days

+3.52%

1 Month

-7.82%

6 Months

-33.79%

Year to Date

-18.78%

1 Year

-23.10%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 28 analysts
BUY
Current Rating
67.334
Target Price
50.33%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Exact Sciences Corp
EXAS
28
CRISPR Therapeutics AG
CRSP
29
Regeneron Pharmaceuticals Inc
REGN
28
Intellia Therapeutics Inc
NTLA
28
Moderna Inc
MRNA
27
IQVIA Holdings Inc
IQV
26
1
2
3
...
112

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(4)
Buy(4)
Indicators
Sell(2)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
1.271
Neutral
RSI(14)
45.224
Neutral
STOCH(KDJ)(9,3,3)
76.715
Neutral
ATR(14)
2.251
Low Volatility
CCI(14)
80.648
Neutral
Williams %R
26.709
Buy
TRIX(12,20)
-0.554
Sell
StochRSI(14)
48.884
Sell
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
45.106
Buy
MA10
44.029
Buy
MA20
43.861
Buy
MA50
49.820
Sell
MA100
54.665
Sell
MA200
55.386
Sell

News

More news coming soon, stay tuned...

Company

Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Company codeEXAS
CompanyExact Sciences Corp
CEOMr. Kevin T. Conroy
Websitehttps://www.exactsciences.com/